Case Study

Cancer Research UK's Path To Rave EDC And The Medidata Platform

GettyImages-1616837193 coworkers tablet

Cancer Research UK, the world’s largest cancer charity dedicated to saving lives through research, embarked on a significant technological upgrade to enhance their clinical trials management. Since 2015, they have been utilizing Medidata's suite of tools, including Rave EDC for electronic data capture, RTSM for randomization and trial supply management, and eCOA for electronic clinical outcome assessment.

To leverage the advanced features of the next-generation Rave EDC system, Cancer Research UK upgraded their platform while ensuring minimal disruption to ongoing studies. By upgrading to Rave EDC and optimizing their platform, they're paving the way for seamless data capture, enhanced productivity, and superior reporting capabilities.

Dive into how this strategic move is propelling them to the forefront of digital transformation in cancer research.

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Medidata, a Dassault Systemes company